Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas

Fig. 1

Immunohistochemical features of PD-L1, CD8+, FOXP3+, and PD-1+. (A-C) PD-L1 is expressed in three major patterns: a “Focal” PD-L1 expression in tumor cells and immune cells (red arrows). b “Diffuse (positive ≥10% of tumor cells)” PD-L1 expression in tumor cells and no staining in immune cells. c PD-L1 expression in immune cells only. (D-F) Note the high population in each line of tumor-infiltrating lymphocytes (TILs); d CD8+/high TILs, e FOXP3+/high TILs, and f PD-1+/high TILs

Back to article page